Department of PICU, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Second Road, Guangzhou, Guangdong, 510080, People's Republic of China.
Department of Cardiovascular pediatrics, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Second Road, Guangzhou, Guangdong, 510080, People's Republic of China.
Ital J Pediatr. 2019 Aug 22;45(1):106. doi: 10.1186/s13052-019-0692-0.
Glycogen storage disease type II (GSD II) is caused by acid alpha-glucosidase (GAA) deficiency. Both infantile-onset and juvenile-onset GSD II lead to proximal muscle weakness and respiratory insufficiency and require mechanical ventilation. However, GSD II is also independently associated with delayed weaning from mechanical ventilation. This study aimed to describe a comprehensive approach including sequential invasive-noninvasive mechanical ventilation weaning and enzyme replacement therapy (ERT) in patients with weaning difficulties.
We studied six difficult-to-wean GSD II (three juvenile-onset, three infantile-onset) patients at the First Affiliated Hospital, Sun Yat-sen University from October 2015 to December 2017. Difficulty in weaning was defined as follows: the need for more than three spontaneous breathing trials or more than 1 week to achieve successful weaning. All patients received comprehensive treatment including sequential invasive-noninvasive mechanical ventilation weaning, ERT and general treatment. Recombinant human acid alpha-glucosidase enzyme therapy (20 mg/kg every 14 days) was used after diagnosis, and Patients 1-6 received ERT for 15.5, 4.5, 2, 2.5, 17, and 2 months, respectively. The therapeutic effect of the comprehensive treatment was observed. The patients' respiratory function and limb muscle strength improved after each ERT session. Patients who successfully completed a spontaneous breathing trial could proceed to extubation, and then start non-invasive ventilation. The patients' age range at initial mechanical ventilation was 3-47 (median 26.5) months, duration of invasive ventilation was 1-36 (median 2.75) months, and duration of noninvasive ventilation was 0-0.6 (median 0.05) month. The patients' nutritional status improved after enhanced nutritional support. Patients 2, 3, and 5 were successfully weaned off the ventilator. Patient 1 underwent tracheal intubation after six weaning failures, and Patients 4 and 6 died after therapy was abandoned by their parents.
Male sex, GSD II type, and the presence of malnutrition and neurological impairment may predict poor respiratory outcomes. The above-described comprehensive sequential invasive-noninvasive mechanical ventilation weaning strategy may increase the success rate of weaning from mechanical ventilation.
糖原贮积病 II 型(GSD II)是由酸性α-葡萄糖苷酶(GAA)缺乏引起的。婴儿期和青少年期 GSD II 均导致近端肌肉无力和呼吸功能不全,需要机械通气。然而,GSD II 也与机械通气撤机困难独立相关。本研究旨在描述一种综合方法,包括序贯有创-无创机械通气撤机和酶替代治疗(ERT),用于撤机困难的患者。
我们研究了中山大学附属第一医院自 2015 年 10 月至 2017 年 12 月期间 6 例撤机困难的 GSD II 患者(3 例青少年起病,3 例婴儿起病)。撤机困难的定义如下:需要超过 3 次自主呼吸试验或超过 1 周才能成功撤机。所有患者均接受了包括序贯有创-无创机械通气撤机、ERT 和一般治疗在内的综合治疗。确诊后,给予重组人酸性α-葡萄糖苷酶酶治疗(20mg/kg,每 14 天 1 次),患者 1-6 分别接受 ERT 治疗 15.5、4.5、2、2.5、17 和 2 个月。观察综合治疗的疗效。每次 ERT 后,患者的呼吸功能和肢体肌肉力量均有所改善。成功完成自主呼吸试验的患者可进行拔管,然后开始无创通气。初始机械通气时患者的年龄范围为 3-47 个月(中位数 26.5 个月),有创通气时间为 1-36 个月(中位数 2.75 个月),无创通气时间为 0-0.6 个月(中位数 0.05 个月)。强化营养支持后,患者的营养状况得到改善。患者 2、3 和 5 成功撤机。患者 1 在经历了 6 次撤机失败后接受了气管插管,患者 4 和 6 因父母放弃治疗而死亡。
男性、GSD II 型、营养不良和神经功能障碍的存在可能预示着呼吸结局不良。上述综合序贯有创-无创机械通气撤机策略可能提高机械通气撤机的成功率。